D. E. Shaw & Co., Inc. Ocular Therapeutix, Inc Transaction History

D. E. Shaw & Co., Inc.

$122 Billion
Q4 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 31,419 shares of OCUL stock, worth $228,730. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,419

Holding current value

$228,730

% of portfolio

0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$8.33 - $11.47 $261,720 - $360,375	31,419 New	31,419 $268,000
Q1 2024 May 15, 2024	SELL	$3.85 - $10.93 $888,168 - $2.52 Million	-230,693 Reduced 59.03%	160,142 $1.46 Million
Q4 2023 Feb 14, 2024	SELL	$2.08 - $4.52 $403,613 - $877,083	-194,045 Reduced 33.18%	390,835 $1.74 Million
Q3 2023 Nov 14, 2023	SELL	$3.14 - $5.04 $223,646 - $358,974	-71,225 Reduced 10.86%	584,880 $1.84 Million
Q2 2023 Aug 14, 2023	SELL	$4.6 - $7.64 $2.04 Million - $3.39 Million	-443,665 Reduced 40.34%	656,105 $3.39 Million
Q1 2023 May 15, 2023	BUY	$2.79 - $6.27 $366,706 - $824,103	131,436 Added 13.57%	1,099,770 $5.8 Million
Q4 2022 Feb 14, 2023	BUY	$2.61 - $4.41 $459,477 - $776,358	176,045 Added 22.22%	968,334 $2.72 Million
Q3 2022 Nov 14, 2022	BUY	$4.09 - $6.5 $179,240 - $284,856	43,824 Added 5.86%	792,289 $3.29 Million
Q2 2022 Aug 15, 2022	BUY	$3.01 - $5.22 $406,130 - $704,318	134,927 Added 21.99%	748,465 $3.01 Million
Q1 2022 May 16, 2022	BUY	$4.83 - $7.35 $646,592 - $983,944	133,870 Added 27.91%	613,538 $3.04 Million
Q4 2021 Feb 14, 2022	SELL	$6.16 - $12.07 $538,593 - $1.06 Million	-87,434 Reduced 15.42%	479,668 $3.34 Million
Q3 2021 Nov 15, 2021	SELL	$9.7 - $14.34 $1.16 Million - $1.72 Million	-120,078 Reduced 17.47%	567,102 $5.67 Million
Q2 2021 Aug 16, 2021	BUY	$13.43 - $19.16 $470,748 - $671,596	35,052 Added 5.38%	687,180 $9.74 Million
Q1 2021 May 17, 2021	SELL	$15.82 - $22.11 $6.29 Million - $8.79 Million	-397,618 Reduced 37.88%	652,128 $10.7 Million
Q4 2020 Feb 16, 2021	BUY	$7.91 - $22.95 $6.14 Million - $17.8 Million	776,758 Added 284.54%	1,049,746 $21.7 Million
Q3 2020 Nov 16, 2020	SELL	$7.36 - $9.87 $1.09 Million - $1.47 Million	-148,546 Reduced 35.24%	272,988 $2.08 Million
Q2 2020 Aug 14, 2020	BUY	$4.67 - $8.95 $1.78 Million - $3.41 Million	381,362 Added 949.32%	421,534 $3.51 Million
Q1 2020 May 15, 2020	BUY	$3.95 - $7.4 $158,679 - $297,272	40,172 New	40,172 $199,000
Q4 2018 Feb 14, 2019	SELL	$3.87 - $7.11 $818,926 - $1.5 Million	-211,609 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$5.42 - $6.99 $203,716 - $262,726	37,586 Added 21.6%	211,609 $1.46 Million
Q2 2018 Aug 14, 2018	BUY	$5.99 - $8.17 $1.04 Million - $1.42 Million	174,023 New	174,023 $1.18 Million
Q1 2018 May 15, 2018	SELL	$4.66 - $7.08 $279,865 - $425,203	-60,057 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$3.73 - $6.37 $10,858 - $18,543	2,911 Added 5.09%	60,057 $267,000
Q3 2017 Nov 14, 2017	BUY	$5.28 - $6.88 $301,730 - $393,164	57,146	57,146 $353,000

Others Institutions Holding OCUL

# of Institutions

186

Shares Held

136M

Call Options Held

284K

Put Options Held

156K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $560M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account